OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 844-875
Open Access | Times Cited: 34
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 844-875
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 57
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 57
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023
Li‐Xiang Ling, Yaobin Ouyang, Yi Hu
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Li‐Xiang Ling, Yaobin Ouyang, Yi Hu
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, et al.
Nanoscale (2024) Vol. 16, Iss. 8, pp. 3881-3914
Closed Access | Times Cited: 11
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, et al.
Nanoscale (2024) Vol. 16, Iss. 8, pp. 3881-3914
Closed Access | Times Cited: 11
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Silvia Silva Romeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5208-5208
Open Access | Times Cited: 13
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Silvia Silva Romeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5208-5208
Open Access | Times Cited: 13
The potential role and mechanism of circRNAs in Ferroptosis: A comprehensive review
Javad Arabpour, Kimia Rezaei, Javad Yaghmoorian Khojini, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155203-155203
Closed Access | Times Cited: 5
Javad Arabpour, Kimia Rezaei, Javad Yaghmoorian Khojini, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155203-155203
Closed Access | Times Cited: 5
Immunotherapeutic Approaches in Ovarian Cancer
Hyunho Yoon, Ayoung Kim, Hoon Jang
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1233-1249
Open Access | Times Cited: 12
Hyunho Yoon, Ayoung Kim, Hoon Jang
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1233-1249
Open Access | Times Cited: 12
Exploring Contemporary Breakthroughs in Utilizing Vesicular Nanocarriers for Breast Cancer Therapy
Nalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 4, pp. 279-303
Closed Access | Times Cited: 4
Nalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 4, pp. 279-303
Closed Access | Times Cited: 4
Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 4
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 4
Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment
Lijuan Guo, Jinsheng Wu, Weifeng Lu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1367-1382
Open Access
Lijuan Guo, Jinsheng Wu, Weifeng Lu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1367-1382
Open Access
Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer
Linlin Zhou, Yinghui Zhang, Jiayu Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Linlin Zhou, Yinghui Zhang, Jiayu Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Organelle-oriented nanomedicines in tumor therapy: Targeting, escaping, or collaborating?
Kexin Tan, Xiao‐Ai Zhang, Jian‐Yuan Yang, et al.
Bioactive Materials (2025) Vol. 49, pp. 291-339
Closed Access
Kexin Tan, Xiao‐Ai Zhang, Jian‐Yuan Yang, et al.
Bioactive Materials (2025) Vol. 49, pp. 291-339
Closed Access
Promising future of breast cancer vaccine asking for multidisciplinary collaboration: a literature review
Zhanyi Zhang, Mengyuan Li, Lei Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Zhanyi Zhang, Mengyuan Li, Lei Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities
Diksha Nagpal, Ravinder Verma, Vineet Mittal, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105049-105049
Closed Access | Times Cited: 8
Diksha Nagpal, Ravinder Verma, Vineet Mittal, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105049-105049
Closed Access | Times Cited: 8
Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy
Pu Yao, Xiaowen Wang, Qianmei Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1827-1827
Open Access | Times Cited: 7
Pu Yao, Xiaowen Wang, Qianmei Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1827-1827
Open Access | Times Cited: 7
Nanoparticles targeting monocytes and macrophages as diagnostic and therapeutic tools for autoimmune diseases
Karen Valdés Álvarez, Mauricio Rojas
Heliyon (2023) Vol. 9, Iss. 9, pp. e19861-e19861
Open Access | Times Cited: 7
Karen Valdés Álvarez, Mauricio Rojas
Heliyon (2023) Vol. 9, Iss. 9, pp. e19861-e19861
Open Access | Times Cited: 7
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 2
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 2
Vaccines in Breast Cancer: Challenges and Breakthroughs
Gul Naz Fatima, Hera Fatma, Shailendra K. Saraf
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2175-2175
Open Access | Times Cited: 6
Gul Naz Fatima, Hera Fatma, Shailendra K. Saraf
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2175-2175
Open Access | Times Cited: 6
Breast cancer vaccines; A comprehensive and updated review
Sulieman Ibraheem Shelash Al‐Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154735-154735
Closed Access | Times Cited: 5
Sulieman Ibraheem Shelash Al‐Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154735-154735
Closed Access | Times Cited: 5
Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis
Maoquan Yang, Mingwei Zhang, Qiong Wang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Maoquan Yang, Mingwei Zhang, Qiong Wang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Graphene quantum dots as nanotherapeutic agents for triple-negative breast cancer: Insights from 3D tumor models
Mohammad Suhaan Dar, P. Rosaiah, J. Bhagyalakshmi, et al.
Coordination Chemistry Reviews (2024) Vol. 523, pp. 216247-216247
Closed Access | Times Cited: 1
Mohammad Suhaan Dar, P. Rosaiah, J. Bhagyalakshmi, et al.
Coordination Chemistry Reviews (2024) Vol. 523, pp. 216247-216247
Closed Access | Times Cited: 1
Integration: Gospel for immune bioinformatician on epitope-based therapy
Baozeng Sun, Junqi Zhang, Zhikui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Baozeng Sun, Junqi Zhang, Zhikui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
